Coverage of glucagon-like peptide-1 receptor agonists and the multi-receptor molecules that followed them: how the class was discovered, what the landmark trials measured, and where the research is heading.
2 articles
From a lizard-venom discovery in the 1990s to the most studied molecules in metabolic science. Here is what the published research actually shows, and where the field is heading next.
Dual agonist against single agonist. What the SURPASS, SURMOUNT, and STEP trial programs measured, and how the two molecules differ at the receptor level.